The Health Communications Core (HCC) provides interdisciplinary support to University of Michigan Comprehensive Cancer Center (UMCCC) Investigators In the design, development, and delivery of research interventions requiring targeted and tailored communications across the continuum of cancer care. The Core provides scientific expertise regarding tailored health communication, individual counseling, intervention design, study protocols, and the development of evaluation instruments;behavioral science expertise and tailored content development;technical engineering and programming, including web, print, mobile device, social media;creative media design and development. Including graphic design, illustration, animation, photography, audio engineering, video production, music composition, and advanced web programming;activities in support of data collection, management, and reporting;assistance in the planning of analyses, interpretation of results, and presentation and publication of research findings;and all aspects of project management. Rapid change in the national and global Information technology landscape has created the unprecedented opportunity and critical need for interactive health communications strategies that can be tailored to the specific health needs of the individual and of special populations. In developing a broad spectrum of interactive health communications interventions for investigators conducting cancer prevention, cancer control, and clinical and translational research, the Health Communications Core (HCC) supports multiple facets of the overall research mission of the University of Michigan Comprehensive Cancer Center (UMCCC). The primary aim of the HCC is to support UMCCC Investigators in the design, development, and delivery of state-of-the-science health communications research programs. Achieving this aim depends on the HCC's organization, staff, and Interactions with UMCCC Investigators. Organizing the multidisciplinary staff and technical resources into a unified, cooperative Core allows the HCC to develop and Implement Interventions In a more effective, efficient manner. This core institutionalizes a long-standing commitment of the University of Michigan's Center for Health Communications Research (CHCR) to provide a robust communications resource for all Cancer Center investigators. The HCC plans significant Interactions with other UMCCC Cores, particularly the proposed Patient and Population Sciences Core, the Cancer Informatics Core, and the Biostatistics Core.

Public Health Relevance

The primary aim of the Core is to support UMCCC Investigators in the design, development, and delivery of state-of-the-science health communications programs. Rapid change In the national and global information technology landscape has created the unprecedented opportunity and critical need for interactive health communications Strategies that can be tailored to the specific health needs of the Individual and of special populations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046592-25
Application #
8559880
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
25
Fiscal Year
2013
Total Cost
$91,674
Indirect Cost
$39,016
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Khoriaty, Rami; Hesketh, Geoffrey G; Bernard, Amélie et al. (2018) Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo. Proc Natl Acad Sci U S A 115:E7748-E7757
Katz, Steven J; Ward, Kevin C; Hamilton, Ann S et al. (2018) Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer. J Clin Oncol 36:1218-1224
Ulintz, Peter J; Greenson, Joel K; Wu, Rong et al. (2018) Lymph Node Metastases in Colon Cancer Are Polyclonal. Clin Cancer Res 24:2214-2224
Qin, Tingting; Zhang, Yanxiao; Zarins, Katie R et al. (2018) Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort. Sci Rep 8:11458
Xu, Shilin; Aguilar, Angelo; Xu, Tianfeng et al. (2018) Design of the First-in-Class, Highly Potent Irreversible Inhibitor Targeting the Menin-MLL Protein-Protein Interaction. Angew Chem Int Ed Engl 57:1601-1605
Crespo, Joel; Wu, Ke; Li, Wei et al. (2018) Human Naive T Cells Express Functional CXCL8 and Promote Tumorigenesis. J Immunol 201:814-820
Manohar, Poorni M; Beesley, Lauren J; Bellile, Emily L et al. (2018) Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer. Clin Nucl Med 43:641-647
Hawley, Sarah T; Li, Yun; An, Lawrence C et al. (2018) Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial. J Clin Oncol 36:659-666
Salami, Simpa S; Hovelson, Daniel H; Kaplan, Jeremy B et al. (2018) Transcriptomic heterogeneity in multifocal prostate cancer. JCI Insight 3:
Smith, Joshua; Kulkarni, Aditi; Birkeland, Andrew C et al. (2018) Whole-Exome Sequencing of Sinonasal Small Cell Carcinoma Arising within a Papillary Schneiderian Carcinoma In Situ. Otolaryngol Head Neck Surg 159:859-865

Showing the most recent 10 out of 1493 publications